Moody’s affirms ‘A2’ rating on WakeMed Health’s bonds

Moody’s Investors Service affirmed the “Aa2” rating on Raleigh, N.C.-based WakeMed Health’s bonds, affecting $400 million of rated debt.

Advertisement

The ratings affirmation is based on a number of factors, including the health system’s solid market share as well as its strong operating performance in fiscal year 2016.

The outlook is stable, reflecting Moody’s Investors Service’s expectation the health system will maintain or improve its operating performance above FY 2016 levels.

More articles on healthcare finance:
Moody’s affirms ‘A1’ rating on Jackson-Madison County General Hospital’s outstanding debt
Moody’s assigns ‘Caa1’ rating to Good Shepherd Health System’s bonds
Moody’s assigns ‘A1’ rating to Children’s Hospital & Medical Center’s bonds

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.